These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

946 related items for PubMed ID: 17219049

  • 1. A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer.
    Duijm LE, Groenewoud JH, Roumen RM, de Koning HJ, Plaisier ML, Fracheboud J.
    Breast Cancer Res Treat; 2007 Nov; 106(1):113-9. PubMed ID: 17219049
    [Abstract] [Full Text] [Related]

  • 2. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
    Ciatto S, Houssami N, Ambrogetti D, Bonardi R, Collini G, Del Turco MR.
    Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
    [Abstract] [Full Text] [Related]

  • 3. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program.
    Hofvind S, Thoresen S, Tretli S.
    Cancer; 2004 Oct 01; 101(7):1501-7. PubMed ID: 15378474
    [Abstract] [Full Text] [Related]

  • 4. [Needle aspiration cytology of the breast: current perspective on the role in diagnosis and management].
    Kocjan G.
    Acta Med Croatica; 2008 Oct 01; 62(4):391-401. PubMed ID: 19205416
    [Abstract] [Full Text] [Related]

  • 5. False-negative breast screening assessment: what lessons can we learn?
    Burrell HC, Evans AJ, Wilson AR, Pinder SE.
    Clin Radiol; 2001 May 01; 56(5):385-8. PubMed ID: 11384136
    [Abstract] [Full Text] [Related]

  • 6. Preoperative axillary staging in breast cancer-saving time and resources.
    Tahir M, Osman KA, Shabbir J, Rogers C, Suarez R, Reynolds T, Bucknall T.
    Breast J; 2008 May 01; 14(4):369-71. PubMed ID: 18540958
    [Abstract] [Full Text] [Related]

  • 7. Variation in the use of percutaneous biopsy for diagnosis of breast abnormalities in Ontario.
    Holloway CM, Saskin R, Brackstone M, Paszat L.
    Ann Surg Oncol; 2007 Oct 01; 14(10):2932-9. PubMed ID: 17619931
    [Abstract] [Full Text] [Related]

  • 8. Contrast-enhanced MR imaging of breast lesions and effect on treatment.
    Schelfout K, Van Goethem M, Kersschot E, Colpaert C, Schelfhout AM, Leyman P, Verslegers I, Biltjes I, Van Den Haute J, Gillardin JP, Tjalma W, Van Der Auwera JC, Buytaert P, De Schepper A.
    Eur J Surg Oncol; 2004 Jun 01; 30(5):501-7. PubMed ID: 15135477
    [Abstract] [Full Text] [Related]

  • 9. Cytology is useful in breast screening: results and long-term follow-up of the Singapore Breast Screening Pilot Project.
    Chew I, Tan Y, Tan PH.
    Cytopathology; 2006 Oct 01; 17(5):227-32. PubMed ID: 16961649
    [Abstract] [Full Text] [Related]

  • 10. The role of magnetic resonance imaging mammography in the surgical management of the index breast cancer.
    Bagley FH.
    Arch Surg; 2004 Apr 01; 139(4):380-3; discussion 383. PubMed ID: 15078704
    [Abstract] [Full Text] [Related]

  • 11. Role of fine-needle aspiration cytology and core biopsy in the preoperative diagnosis of screen-detected breast carcinoma.
    Lieske B, Ravichandran D, Wright D.
    Br J Cancer; 2006 Jul 03; 95(1):62-6. PubMed ID: 16755293
    [Abstract] [Full Text] [Related]

  • 12. 15. Image-guided breast biopsy.
    Ralleigh G, Michell MJ.
    Int J Clin Pract; 2002 Oct 03; 56(8):583-7. PubMed ID: 12425367
    [Abstract] [Full Text] [Related]

  • 13. [Non palpable lesions of the breast: the Mammotome-biopsy in the preoperative management of breast cancer].
    Ceccarelli G, Casciola L, Battistini I, Stefanoni M, Spaziani A, Conti D, Di Zitti L, Valeri R, Bartoli A, Bellochi R, Rambotti M, Pisanelli MC.
    G Chir; 2005 May 03; 26(5):187-93. PubMed ID: 16184700
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Stereotactic fine-needle aspiration cytology of nonpalpable breast lesions: Institut Curie's experience of 243 histologically correlated cases.
    Côté JF, Klijanienko J, Meunier M, Zafrani B, Thibault F, Clough K, Asselain B, Vielh P.
    Cancer; 1998 Apr 25; 84(2):77-83. PubMed ID: 9570209
    [Abstract] [Full Text] [Related]

  • 17. Mammography-guided stereotactic fine-needle aspiration cytology of nonpalpable breast lesions: prospective comparison with surgical biopsy results.
    Fajardo LL, Davis JR, Wiens JL, Trego DC.
    AJR Am J Roentgenol; 1990 Nov 25; 155(5):977-81. PubMed ID: 2120967
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The "EVA" Trial: Evaluation of the Efficacy of Diagnostic Methods (Mammography, Ultrasound, MRI) in the secondary and tertiary prevention of familial breast cancer. Preliminary results after the first half of the study period].
    Kuhl CK, Schrading S, Weigel S, Nüssle-Kügele K, Sittek H, Arand B, Morakkabati N, Leutner C, Tombach B, Nordhoff D, Perlet C, Rieber A, Heindel W, Brambs HJ, Schild H.
    Rofo; 2005 Jun 25; 177(6):818-27. PubMed ID: 15902631
    [Abstract] [Full Text] [Related]

  • 20. The contribution of clinical breast examination to the accuracy of breast screening.
    Chiarelli AM, Majpruz V, Brown P, Thériault M, Shumak R, Mai V.
    J Natl Cancer Inst; 2009 Sep 16; 101(18):1236-43. PubMed ID: 19720967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.